Veritas Pharma Valuation
| VRTHF Stock | USD 0 0.00 0.00% |
Veritas Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Veritas Pharma from inspecting the company fundamentals such as Price To Book of 0.43 X, shares outstanding of 71.14 M, and Return On Equity of -5.67 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Veritas Pharma's price fluctuation is very steady at this time. Calculation of the real value of Veritas Pharma is based on 3 months time horizon. Increasing Veritas Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Veritas pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Veritas Pharma. Since Veritas Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Veritas Pink Sheet. However, Veritas Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0015 | Real 0.00126 | Hype 0.0015 | Naive 0.0015 |
The real value of Veritas Pink Sheet, also known as its intrinsic value, is the underlying worth of Veritas Pharma Company, which is reflected in its stock price. It is based on Veritas Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Veritas Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Veritas Pharma helps investors to forecast how Veritas pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Veritas Pharma more accurately as focusing exclusively on Veritas Pharma's fundamentals will not take into account other important factors: Veritas Pharma Total Value Analysis
Veritas Pharma is at this time forecasted to have takeover price of 1.77 M with market capitalization of 1.59 M, debt of 765.63 K, and cash on hands of 125.27 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Veritas Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.77 M | 1.59 M | 765.63 K | 125.27 K |
Veritas Pharma Asset Utilization
One of the ways to look at asset utilization of Veritas is to check how much profit was generated for every dollar of assets it reports. Veritas Pharma has a negative utilization of assets of -0.21 %, losing $0.002124 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Veritas Pharma shows how discouraging it operates for each dollar spent on its assets.Veritas Pharma Ownership Allocation
Veritas Pharma shows a total of 71.14 Million outstanding shares. Veritas Pharma maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Veritas Pharma Profitability Analysis
Net Loss for the year was (2.29 M) with loss before overhead, payroll, taxes, and interest of (112.96 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Veritas Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Veritas Pharma and how it compares across the competition.
About Veritas Pharma Valuation
The pink sheet valuation mechanism determines Veritas Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Veritas Pharma. We calculate exposure to Veritas Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Veritas Pharma's related companies.Indigenous Bloom Hemp Corp. focuses on the production of hemp products for commercial use. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. Indigenous Bloom is traded on OTC Exchange in the United States.
8 Steps to conduct Veritas Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Veritas Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Veritas Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Veritas Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Veritas Pharma's revenue streams: Identify Veritas Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Veritas Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Veritas Pharma's growth potential: Evaluate Veritas Pharma's management, business model, and growth potential.
- Determine Veritas Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Veritas Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Veritas Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Veritas Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -3.1 M | |
| Shares Float | 62.5 M |
Complementary Tools for Veritas Pink Sheet analysis
When running Veritas Pharma's price analysis, check to measure Veritas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veritas Pharma is operating at the current time. Most of Veritas Pharma's value examination focuses on studying past and present price action to predict the probability of Veritas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veritas Pharma's price. Additionally, you may evaluate how the addition of Veritas Pharma to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |